Drug Patent Expirations in February 2010

Drug Patent Expirations in February 2010

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
ZAGAM Mylan sparfloxacin 4,795,751 Feb 4, 2010
TEVETEN Abbott eprosartan mesylate 5,185,351 Feb 9, 2010
MYOVIEW Ge Healthcare technetium tc-99m tetrofosmin kit 5,045,302 Feb 9, 2010
TEVETEN HCT Abbott eprosartan mesylate; hydrochlorothiazide 5,185,351 Feb 9, 2010
HYZAAR Merck hydrochlorothiazide; losartan potassium 5,138,069*PED Feb 11, 2010
COZAAR Merck losartan potassium 5,138,069*PED Feb 11, 2010
EXUBERA Pfizer insulin recombinant human RE37872 Feb 12, 2010
EXUBERA Pfizer insulin recombinant human RE38385 Feb 12, 2010
MEPRON Glaxosmithkline atovaquone 4,981,874*PED Feb 15, 2010
NITRO-DUR Key Pharms nitroglycerin 5,186,938 Feb 16, 2010
SANDIMMUNE Novartis cyclosporine 7,511,014 Feb 16, 2010
ALDARA Graceway imiquimod 4,689,338*PED Feb 25, 2010

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.Courtesy of DrugPatentWatch.com


Leave a Reply